Publications by authors named "Matthew Paulson"

Claim this Profile
N
Narrative review of strategies for blood product shelf-life extension.
Mike Akaraphanth, Jessica Oudakker, Matthew Paulson, Michael Adam Meledeo, Kristin M Reddoch-Cardenas

Transfusion· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Market Analysis of Video Laryngoscopy Equipment for the Role 1 Setting.
Robert G Fuller, Marika A Rossetto, Matthew W Paulson, Michael D April, Adit A Ginde

Mil Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Prehospital Neck Wound Survivability and Battlefield Medical Evacuation Time in Afghanistan.
Matthew W Paulson, Marika Rossetto, Jerome T McKay, Vikhyat S Bebarta, Kathleen Flarity

Mil Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehospital Pharmacotherapy in Moderate and Severe Traumatic Brain Injury: A Systematic Review.
William Coburn, Zachary Trottier, Ricardo I Villarreal, Matthew W Paulson, Scott C Woodard

Med J (Ft Sam Houst Tex)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from the Fallen: An After-Action Review of Prehospital Casualty Data during the Global War on Terror.
Matthew W Paulson, John D Hesling, Steven G Schauer, Robert A De Lorenzo

Med J (Ft Sam Houst Tex)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Characterizing pediatric supermassive transfusion and the contributing injury patterns in the combat environment" [American Journal of Emergency Medicine 51 (2022) 139-143].
John D Hesling, Matthew W Paulson, Jerome T McKay, Vikhyat S Bebarta, Kathleen Flarity

Am J Emerg Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Product Administration During the Role 1 Phase of Care: The Prehospital Trauma Registry Experience.
Andrew D Fisher, Matthew W Paulson, Jerome T McKay, James Bynum, Kathleen M Flarity

Mil Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing pediatric supermassive transfusion and the contributing injury patterns in the combat environment.
John D Hesling, Matthew W Paulson, Jerome T McKay, Vikhyat S Bebarta, Kathleen Flarity

Am J Emerg Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Descriptive Analysis of Battlefield First Responder and Combat Lifesaver Interventions during the Role 1 Phase of Care.
Matthew W Paulson, John D Hesling, Jerome T McKay, Vikhyat S Bebarta, Kathleen Flarity

Med J (Ft Sam Houst Tex)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials.
Matthew L Paulson, Chunhua Weng

AMIA Annu Symp Proc· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interaction.
Xiaojun Xu, Hong Thai, Kathryn M Kitrinos, Guoliang Xia, Anuj Gaggar, Matthew Paulson

BMC Bioinformatics· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin.
Zobair M Younossi, Maria Stepanova, Michael Estep, Francesco Negro, Paul J Clark, Matthew Paulson

J Hepatol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection.
Aaron F Carlin, Paula Aristizabal, Qinghua Song, Huan Wang, Matthew S Paulson

Hepatology· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.
David Nelson, Eric M Yoshida, Matthew S Paulson, Paul N Hengen, Dongliang Ge

Antivir Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.
Jennifer C Lin, François Habersetzer, Maribel Rodriguez-Torres, Nezam Afdhal, Eric J Lawitz, Matthew S Paulson

J Infect Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small-molecule inhibitor of hepatitis C virus infectivity.
Caroline O Bush, Maria V Pokrovskii, Roland Saito, Philip Morganelli, Eda Canales, Matthew S Paulson

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymerase.
I-Hung Shih, Inge Vliegen, Betty Peng, Huiling Yang, Christy Hebner, Matthew Paulson

Antimicrob Agents Chemother· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer.
Heather L McArthur, Hope Rugo, Benjamin Nulsen, Laura Hawks, Jill Grothusen, Matthew Paulson

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of clinically relevant protease inhibitor-resistant viruses using the genotype 2a hepatitis C virus infection system.
Guofeng Cheng, Katie Chan, Huiling Yang, Amy Corsa, Maria Pokrovskii, Matthew Paulson

Antimicrob Agents Chemother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.
Maria V Pokrovskii, Caroline O Bush, Rudolf K F Beran, Margaret F Robinson, Guofeng Cheng, Matthew S Paulson

J Virol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and quantitation of infectious hepatitis C virus derived from cell culture (HCVcc).
Matthew S Paulson

Curr Protoc Pharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.
Tiffany A Traina, Hope S Rugo, James F Caravelli, Sujata Patil, Benjamin Yeh, Matthew Paulson

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus.
Matthew S Paulson, Huiling Yang, I-hung Shih, Joy Y Feng, Eric M Mabery

Antiviral Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted imidazopyridines as potent inhibitors of HCV replication.
Inge Vliegen, Jan Paeshuyse, Tine De Burghgraeve, Laura S Lehman, Matthew Paulson

J Hepatol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.
Philip Meuleman, Joseph Hesselgesser, Matthew Paulson, Thomas Vanwolleghem, Isabelle Desombere

Hepatology· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis